Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hanwha Ocean (042660) – Decision on Lawsuit or Legal Proceedings (Claims Above Certain Amount) / 2025-01-15 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Hana | HBM Visibility · Client Positioning · Technology Differentiation / 2025-07-25 RESEARCH
  • [Disclosure] Hanwha Aerospace (012450) – Supply Contract (Correction) / 2024-04-12 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – Kyobo Securities | 4Q25 Review · AI Server MLCC · FC-BGA Expansion / 2026-01-26 RESEARCH
  • [Disclosure] ISU PETASYS (007660) – Notice of Annual General Meeting of Shareholders / 2025-03-07 Semiconductors
  • [Disclosure] Hanwha Systems (272210) – (Correction) Sales / Supply Contract / 2024-12-30 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Decision on Paid-in Capital Increase / 2025-12-22 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – Daishin Securities | AI & Automotive Mix · Big Tech Supply Expansion · Valuation Re-rating / 2025-12-23 RESEARCH

[Disclosure] Celltrion (068270) – Provisional Separate Financial Results / 2025-02-25

Posted on February 25, 2025August 6, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion reported Q4 2024 separate revenue of KRW 1.06T (up 235.96% YoY) and operating profit of KRW 407.5B, with full-year 2024 cumulative separate revenue reaching KRW 3.71T, an increase of 97.99% YoY.

📊 Key Disclosure Content & Financial Highlights

  1. Overview
  • Company: Celltrion, Inc. (Stock Code: 068270)
  • Disclosure Type: Earnings Release (Provisional Separate Financial Results)
  • Disclosure Date: 2025-02-25
  1. Q4 2024 Quarterly Results (Separate Basis, Unit: KRW Million, %)
  • Revenue: KRW 1,057,839M (approx. KRW 1.06T)
    • QoQ (vs. Q3 2024): +1.72%
    • YoY (vs. Q4 2023): +235.96%
  • Operating Profit: KRW 407,521M (approx. KRW 407.5B)
    • QoQ (vs. Q3 2024): -11.73%
    • YoY (vs. Q4 2023): +1,476.91%
  • Income Before Income Taxes: KRW 485,588M (+6,804.42% YoY)
  • Net Income: KRW 378,578M (+1,223.19% YoY)
  1. FY2024 Full-Year Cumulative Results (Separate Basis, Unit: KRW Million, %)
  • Revenue: KRW 3,709,214M (approx. KRW 3.71T, +97.99% YoY)
  • Operating Profit: KRW 1,211,014M (approx. KRW 1.21T, +89.67% YoY)
  • Income Before Income Taxes: KRW 1,271,853M (+86.36% YoY)
  • Net Income: KRW 1,004,841M (approx. KRW 1.00T, +78.39% YoY)
  1. Additional Notes
  • Figures are internal provisional estimates subject to change upon external audit completion.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Audited Financial Statements and Final Performance Confirmation

This disclosure serves as official notification of Celltrion’s provisional Q4 and full-year 2024 separate performance. Reviewing whether these provisional figures are finalized without material adjustments in the audited financial statements and Annual General Meeting approvals is important for confirming the reliability of the earnings data. Relevant details can be confirmed through subsequent audit reports, annual reports, and AGM outcome disclosures.

📢 Disclaimer & Source Notice

Source: This content was structured and generated based on official disclosure data from the Financial Supervisory Service’s DART system.

Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Celltrion (068270) – Provisional Consolidated Financial Results / 2025-02-25
Next Post: [Disclosure] Celltrion (068270) – Change in Revenue or Profit/Loss Structure Exceeding 15% / 2025-02-25

Related Posts

  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2025-12-30 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – Setting of Record Date or Period for Suspension of Entry of Change in Shareholders / 2025-12-16 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Announcement / 2026-05-06 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Organization of Investor Relations Event / 2026-01-20 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Acquisition of Shares and Equity Securities of Other Corporations / 2025-11-24 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2024-11-14 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – iM Securities | Legacy Memory Deceleration · Relative HBM Stability · Hold Rating Maintained / 2024-10-25 RESEARCH
  • [Disclosure] Samsung Biologics (207940) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2026-07-20 Disclosures
  • [Disclosure] LEENO Industrial (058470) – Investor Relations (IR) Holding / 2025-08-26 Disclosures
  • [Research] SK hynix (000660 / SKHY) – SK Securities | Ongoing Earnings Growth Cycle · HBM3e Expansion · Target Price Cut / 2024-10-04 RESEARCH
  • [Disclosure] KEPCO (015760 / KEP) – Financial Results Disclosure Schedule Announcement / 2025-11-10 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Decision on Rights Offering / 2025-04-30 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Compliance Program (CP) Operations Status / 2025-10-30 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · ADR Listing · Valuation Re-rating / 2026-03-23 RESEARCH

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme